GGO Vergunningendatabase

Zoekcriteria

1. Rechtspersoon:
2. Uitgangs-organisme:
3. Procedure: Alle MA IG IM-MV IM-L
4. Dossiernummer:

1. Status: Alle Ter inzage Teruggetrokken Vergunning onherroepelijk In behandeling Besluit genomen Werkzaamheden gestart Kennisgeving niet ingestemd Besluit geweigerd Procedure afgerond Vergunning vernietigd Intrekkingsbesluit onherroepelijk Vergunning verleend
2. Datum vergunning vanaf:
3. Datum vergunning t/m:

1. Trefwoorden:

Zoekresultaat

IM-MV 19-002_006	Universitair Medisch Centrum Utrecht	Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells	15-09-2022	Vergunning verleend
IM-MV 20-001_004	UMCG	Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy.	16-09-2022	Vergunning verleend
IM-MV 21-011_000	AMC	AAV clinical vectors with a target nuclease as insert, used in vivo, to treat and/or prevent disease	12-09-2022	Vergunning verleend
IM-MV 21-014_003	LUMC	Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy	16-09-2022	Vergunning verleend
IM-MV 21-015_003	Erasmus MC	Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy	16-09-2022	Vergunning verleend